The study authors conducted a systematic review and meta-analysis to assess the overall efficacy and safety of low-dose direct oral anticoagulants vs placebo on a background of antiplatelet therapy.
Investigators report findings from the ACTION trial assessing outcomes of therapeutic vs prophylactic oral anticoagulant use among hospitalized adult patients with COVID-19 and elevated D-dimer concentration.
Atrial Fibrillation risk was examined for patients with cancer from 2009 through 2017.
Study investigators assessed whether cardiac axis deviation may indicate cardiac function abnormalities, allowing for predictions of disease severity and mortality.
Albuminuria, retinopathy, and periphery neuropathy were all microvascular complications associated with reduced left ventricle systolic function.
Investigators analyzed mortality and clinical, laboratory, and echocardiography parameters possibly impacting health outcomes in BCPE vs BCNE.
The utility of low-dose computed tomography (LDCT) performed during a lung cancer screening in revealing the degree of aortic valve calcification AVC was examined.
This review and meta-analysis evaluated LA thrombus in patients with AF/AFL on continuous oral anticoagulation therapy for at least 3 weeks.
The primary objective of this study was to assess whether the potential independent effects of secondary hyperparathyroidism on the risk for CKD progression and cardiovascular event incidence in CKD patients act as effect modifiers.
Treatments, complications, and survival rates in patients with cancer with a left ventricular assist device (LVAD) are reviewed.
